Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer

NCT04436393 is registered in ClinicalTrials.gov with Guardant Health, Inc. as lead sponsor.

NCT NCT04436393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04436393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Lead sponsor
Guardant Health, Inc.
Phase
Observational
Overall status
Completed
Start date
July 2, 2020
Completion date
March 17, 2022
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer